Date published: 2026-2-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

XRCC4 Activators

XRCC4, or X-ray repair cross-complementing protein 4, is a crucial player in the process of DNA double-strand break (DSB) repair, particularly in the non-homologous end joining (NHEJ) pathway. NHEJ is a major mechanism employed by cells to repair DSBs, a type of DNA damage that can arise from various sources such as ionizing radiation, reactive oxygen species, and genotoxic chemicals. XRCC4 functions as a scaffold protein, facilitating the assembly and stabilization of the DNA ligase IV complex, which is essential for the final ligation step of NHEJ repair. Additionally, XRCC4 interacts with other proteins involved in NHEJ, such as Ku70/Ku80 heterodimer and DNA-PKcs, to coordinate the repair process and ensure efficient DSB repair. Beyond its role in DSB repair, XRCC4 also participates in other DNA repair pathways and contributes to the maintenance of genomic stability, making it indispensable for cellular survival and integrity.

The activation of XRCC4 involves multiple regulatory mechanisms that ensure its proper function in DNA repair processes. One key mechanism of XRCC4 activation is post-translational modification, such as phosphorylation, which regulates its stability, localization, and interaction with other repair factors. Phosphorylation of XRCC4 by DNA-dependent protein kinase (DNA-PK) and other kinases enhances its recruitment to DSB sites and promotes the assembly of the DNA ligase IV complex, facilitating efficient DSB repair. Additionally, XRCC4 activation can be regulated by signaling pathways activated in response to DNA damage, such as the ATM (ataxia-telangiectasia mutated) and ATR (ataxia-telangiectasia and Rad3-related) pathways. These pathways phosphorylate XRCC4 and other NHEJ factors, orchestrating their recruitment to DSB sites and promoting repair initiation. Understanding the intricate mechanisms governing XRCC4 activation is essential for unraveling its roles in DNA repair and genomic stability maintenance.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

SN 38

86639-52-3sc-203697
sc-203697A
sc-203697B
10 mg
50 mg
500 mg
$119.00
$342.00
$883.00
19
(3)

Inhibition of topoisomerase I indirectly activates XRCC4 by inducing DNA damage that necessitates XRCC4's role in NHEJ DNA repair to fix the damage.

Olaparib

763113-22-0sc-302017
sc-302017A
sc-302017B
250 mg
500 mg
1 g
$210.00
$305.00
$495.00
10
(1)

Inhibition of PARP indirectly activates XRCC4 as PARP inhibitors lead to the accumulation of DNA damage that requires XRCC4-mediated NHEJ DNA repair for resolution.

Bleomycin

11056-06-7sc-507293
5 mg
$275.00
5
(0)

Bleomycin indirectly activates XRCC4 by generating DNA damage that requires XRCC4-mediated NHEJ DNA repair for resolution.